BioTime prevailing Real Value cannot be determined due to lack of data. The current price of BioTime is S469.8. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Macroaxis approximates value of BioTime from analyzing the firm fundamentals such as Shares Outstanding of 126.88M, Return On Equity of
(39.03)% and Operating Margin of (771.52)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
|Horizon||30 Days Login to change|
BioTime is number one stock in price to sales category among related companies. It is rated second in price to book category among related companies fabricating about 3.08 of Price to Book per Price to Sales.
|Price to Sales ( times )|
|Price to Book ( times )|
December 16, 2018
BioTime is Unknown risk asset. Calculation of real value of BioTime is based on 2 months time horizon. Increasing BioTime time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.